Clinical Trial Update: Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of autologous bone marrow mononuclear cells processed by two methods in patients with chronic limb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Arterial Disease
• Thromboangiitis Obliterans

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Critical Limb Ischemia, Peripheral Arterial Disease | Phase 1, Phase 2 | Status: UNKNOWN